News

2021.09.02

news Our efforts for the medical application of artificial intelligence (AI) (hemodialysis, respiratory diagnosis, etc.) were featured in Nikkei Biotechnology and Business

2021.08.18

news Notice Regarding Approval of Listing on the Tokyo Stock Exchange Mothers Market

2021.07.19

news Nikkei Sangyo Shimbun featured our work on AI project

2021.07.06

news Development of a swallowing function evaluation system using artificial intelligence was featured in the Chemical Daily.

2021.06.25

news Collaboration agreement with Nipro Corporation on chronic dialysis system support was featured in the morning edition of Nihon Keizai Shimbun

2021.06.25

news Collaboration Agreement with Nipro Corporation for the Development of Chronic Dialysis Support System.

2021.01.17

news Option agreement with Daiichi Sankyo Co., Ltd. for the treatment of respiratory diseases including COVID-19 pneumonia and other lung injuries

2020.12.10

news Our research on a drug (RS5614) for the treatment of lung injury associated with new coronavirus infections was published in the Bunshun Mook “Super Doctors Teach Us the Latest Treatment 2021”.

2020.12.04

news Investigator-initiated clinical trial on RS5614, for the treatment of lung injuries associated with COVIC-19 infections at Northwestern Memorial hospital, was reported by WGN-TV, Chicago news.

2020.11.27

news Investigator-initiated clinical trial to be started at Northwestern University as one of our U.S. initiatives for the treatment (RS5614) of lung injuries associated with COVID-19 infections (ClinicalTrials.gov: NCT04634799).